Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00490841 · ClinicalTrials.gov registry record · NA
The HERCULES Trial - A Safety and Effectiveness Study of the Herculink Elite Renal Stent to Treat Renal Artery Stenosis
A NA study, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 202
- Enrollment target
NCT00490841 is a NA study that has completed, run by Abbott Medical Devices. The registered enrollment target is 202 participants.
The verdict
NCT00490841, a NA study, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 202 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether the Herculink Elite Renal Stent System is safe and effective in the treatment of renal artery stenosis in patients with less than optimal angioplasty results and uncontrolled hypertension. CAUTION: The Herculink Elite Renal Stent System Is An Investigational Device. Limited by Federal (U.S.) Law to Investigational Use Only.
Interventions
- DEVICE Herculink Elite Renal Stent System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 202 participants |
| Start Date | 2007-08 |
| Est. Completion | 2012-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00490841
The ClinicalTrials.gov registry entry for NCT00490841 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 202 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Herculink Elite Renal Stent System is the first listed.
NCT00490841 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00490841 about?
NCT00490841 is a clinical study titled "The HERCULES Trial - A Safety and Effectiveness Study of the Herculink Elite Renal Stent to Treat Renal Artery Stenosis". The purpose of this study is to determine whether the Herculink Elite Renal Stent System is safe and effective in the treatment of renal artery stenosis in patients with less than optimal angioplasty results and uncontrolled hypertension. CAUTION: The Herculink Elite Renal Stent System Is An Invest...
What is the current status of trial NCT00490841?
This trial is currently completed. It is a NA study. The enrollment target is 202 participants. The study started on 2007-08. Estimated completion is 2012-12.
What interventions are being tested in trial NCT00490841?
The interventions under investigation include: Herculink Elite Renal Stent System (DEVICE).
Who is sponsoring clinical trial NCT00490841?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.